SciTransfer
Organization

ATONOMICS AS

Danish health-tech SME specializing in point-of-care diagnostics and eHealth solutions for chronic disease management.

Technology SMEhealthDKSMENo active H2020 projectsThin data (2/5)
H2020 projects
3
As coordinator
1
Total EC funding
€945K
Unique partners
26
What they do

Their core work

Atonomics is a Danish SME operating in the health technology and diagnostics space, with a focus on patient-centered care solutions. Their coordinated project PaDiCare targeted diabetes self-management in ambulatory settings, suggesting core competence in point-of-care diagnostic devices or digital health tools for chronic disease monitoring. They have also contributed to eHealth solutions for rheumatology (ELECTOR) and research on how green microenvironments affect health and well-being (CHARMED), indicating broader interest in health monitoring and preventive care technologies.

Core expertise

What they specialise in

Point-of-care diagnostics for chronic diseaseprimary
2 projects

Coordinated PaDiCare (diabetes ambulatory care) and participated in ELECTOR (eHealth for rheumatology), both involving patient-side health monitoring.

eHealth and patient empowermentprimary
2 projects

PaDiCare focused on patient-empowered diabetes care; ELECTOR addressed eHealth applications in rheumatology.

Health and well-being in built environmentsemerging
1 project

CHARMED project studied how green microenvironments impact health, well-being, and aging — a departure from their core diagnostics work.

Evolution & trajectory

How they've shifted over time

Early focus
eHealth diagnostics and chronic disease
Recent focus
Environmental health and well-being

Atonomics entered H2020 in 2015 with a clear focus on clinical eHealth applications (rheumatology, diabetes diagnostics), then broadened in 2017 toward environmental health and well-being research through CHARMED. The shift from device-oriented health tech toward health tourism and green environments suggests an exploration of wellness and preventive health markets. However, with only three projects over a short window (2015–2017), this may reflect opportunistic participation rather than a deliberate strategic pivot.

Their trajectory hints at a move from clinical diagnostics toward broader wellness and preventive health applications, though their H2020 activity stopped in 2017 so current direction is uncertain.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European8 countries collaborated

Atonomics operates as both a coordinator (PaDiCare, an SME Instrument Phase 1 project) and a consortium participant. With 26 unique partners across 8 countries from just 3 projects, they have joined medium-to-large consortia rather than leading them. Their single coordination was a small feasibility study, suggesting they are comfortable contributing specialized expertise to larger teams while occasionally testing their own ideas through SME-targeted funding.

Despite only three projects, Atonomics has built connections with 26 partners across 8 European countries, primarily through health-focused consortia. This suggests exposure to a diverse set of research institutions and clinical partners across Europe.

Why partner with them

What sets them apart

As a Danish health-tech SME, Atonomics bridges the gap between diagnostic technology and patient-centered care delivery — a niche that combines hardware/sensor know-how with digital health integration. Their experience spans both clinical applications (diabetes, rheumatology) and environmental health research, giving them an unusual cross-disciplinary perspective. For consortium builders, they offer an SME partner with direct experience navigating the SME Instrument and contributing diagnostic expertise to larger RIA and MSCA projects.

Notable projects

Highlights from their portfolio

  • ELECTOR
    Largest project by funding (EUR 787K), focused on eHealth in rheumatology — represents their core health technology expertise.
  • PaDiCare
    Their only coordinated project, an SME Instrument Phase 1 feasibility study for patient-empowered diabetes care — signals their own product ambitions.
  • CHARMED
    An MSCA-RISE project exploring green microenvironments and well-being, showing breadth beyond their core diagnostics focus.
Cross-sector capabilities
digital health and eHealth platformswellness and health tourismenvironmental health monitoringaging and active living
Analysis note: Profile based on only 3 H2020 projects (2015–2017) with limited keyword data. No website available for verification. The company name suggests diagnostics focus, but project descriptions are brief. H2020 activity appears to have ceased after 2017, so current operations and focus may differ significantly from this profile.